School of Nursing, Columbia University Medical Center, New York, New York.
Department of Pediatrics, Columbia University Medical Center, New York, New York.
Infect Control Hosp Epidemiol. 2019 Oct;40(10):1107-1115. doi: 10.1017/ice.2019.215. Epub 2019 Jul 30.
Multidrug-resistant organisms (MDROs) cause ~5%-10% of infections in hospitalized children, leading to an increased risk of death, prolonged hospitalization, and additional costs. Antibiotic exposure is considered a driving factor of MDRO acquisition; however, consensus regarding the impact of antibiotic factors, especially in children, is lacking. We conducted a systematic review to examine the relationship between antibiotic use and subsequent healthcare-associated infection or colonization with an MDRO in children.
Systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guideline.
We searched PubMed and Embase for all English, peer-reviewed original research studies published before September 2018. Included studies evaluated hospitalized children, antibiotic use as an exposure, and bacterial MDRO as an outcome.
Of the 535 studies initially identified, 29 met the inclusion criteria. Overall, a positive association was identified in most studies evaluating a specific antibiotic exposure (17 of 21, 81%), duration of antibiotics (9 of 12, 75%), and number of antibiotics received (2 of 3, 67%). Those studies that evaluated any antibiotic exposure had mixed results (5 of 10, 50%). Study sites, populations, and definitions of antibiotic use and MDROs varied widely.
Published studies evaluating this relationship are limited and are of mixed quality. Limitations include observation bias in recall of antibiotic exposure, variations in case definitions, and lack of evaluation of antibiotic dosing and appropriateness. Additional studies exploring the impact of antibiotic use and MDRO acquisition may be needed to develop effective antibiotic stewardship programs for hospitalized children.
耐多药菌(MDROs)导致住院儿童约 5%-10%的感染,增加了死亡、住院时间延长和额外费用的风险。抗生素暴露被认为是 MDRO 获得的驱动因素;然而,关于抗生素因素的影响,尤其是在儿童中的影响,尚未达成共识。我们进行了一项系统评价,以检查抗生素使用与随后的医疗保健相关感染或 MDRO 定植在儿童中的关系。
按照系统评价和荟萃分析的首选报告项目(PRISMA)指南进行系统评价。
我们在 PubMed 和 Embase 中搜索了所有 2018 年 9 月之前发表的英文同行评审原始研究。纳入的研究评估了住院儿童、抗生素使用作为暴露因素和细菌 MDRO 作为结果。
最初确定的 535 项研究中,有 29 项符合纳入标准。总体而言,在评估特定抗生素暴露(17/21,81%)、抗生素使用时间(9/12,75%)和使用抗生素种类(2/3,67%)的大多数研究中都发现了阳性关联。那些评估任何抗生素暴露的研究则结果不一(10/50,50%)。研究地点、人群以及抗生素使用和 MDRO 的定义差异很大。
评估这种关系的已发表研究有限,且质量参差不齐。局限性包括回忆抗生素暴露的观察偏倚、病例定义的差异以及缺乏对抗生素剂量和适当性的评估。可能需要进一步研究探索抗生素使用和 MDRO 获得的影响,以制定针对住院儿童的有效的抗生素管理计划。